Article | January 7, 2021

Why Collaboration Is Important To TMF Quality

By Chris McSpiritt, Senior Director, Clinical Strategy, Veeva Systems

teamwork puzzle collaboration 450x300

This is part one in a series about how collaboration can impact TMF quality and inspection readiness.

In the race for a COVID vaccine, we’re seeing amazing collaboration between the private sector, government, and academic research. Collaboration can become a force multiplier for speed and impact, leading to greater productivity, increased efficiency, and better outcomes.

If collaboration isn’t the heart of your solution, your organization will struggle as the trial landscape becomes increasingly complex. Pharma companies are spending more and more on partners and CROs. In fact, some sponsors are hiring multiple CROs to handle individual functions, such as one to execute the trial, one to monitor the trial, one for data management, one for feasibility and startup, etc. With so many hands in the cookie jar, driving collaboration among the increasing number of actors is critical to successfully conducting the study and maintaining the TMF properly.

VIEW THE ARTICLE!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Clinical Leader? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
I'm interested in newsletter subscriptions.
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: